See analyst estimates and all valuation multiples for Health & Beauty
Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
---|---|---|---|
$403B | 6.9x | 15.3x | |
$391B | 4.6x | 16.8x | |
$234B | 4.5x | 18.9x | |
$176B | 2.5x | 11.9x | |
$77.9B | 3.9x | 15.7x | |
$70.0B | 1.3x | 6.1x | |
$67.8B | 9.1x | 39.6x | |
$57.0B | 3.0x | 10.5x | |
$54.8B | 3.6x | 14.4x | |
$49.7B | 3.2x | 13.7x | |
$48.8B | 5.2x | 21.2x | |
$39.3B | 7.9x | 34.5x | |
$37.9B | 2.6x | 19.5x | |
$33.3B | 1.3x | 7.4x | |
$25.5B | 2.2x | 12.4x | |
$25.0B | 4.1x | 17.8x | |
$23.5B | 2.1x | 13.4x | |
$23.0B | 2.3x | 6.6x | |
$21.1B | 1.8x | 12.5x | |
$20.8B | 1.4x | 7.6x | |
$15.3B | 8.9x | 41.8x | |
$13.5B | 8.9x | 35.0x | |
$12.2B | 2.1x | 14.8x | |
$11.7B | 2.0x | 10.1x | |
$10.9B | 8.3x | 42.0x | |
$10.8B | 7.2x | 38.6x | |
$10.0B | 1.4x | 7.8x | |
$8.4B | 1.2x | 11.8x | |
$8.3B | 1.4x | 7.6x | |
$7.6B | 10.5x | 32.3x | |
$7.0B | 8.0x | 19.2x | |
$7.0B | 1.6x | 9.1x | |
$6.6B | 2.4x | 10.5x | |
$6.5B | 4.6x | 21.3x | |
$6.0B | 13.3x | 42.0x | |
$5.9B | 1.9x | 13.8x | |
$5.0B | 9.9x | 41.5x | |
$4.9B | 6.8x | 32.0x | |
$4.6B | 4.1x | 12.3x | |
$4.6B | n/a | n/a | |
$4.2B | 2.8x | 14.1x | |
$4.2B | 12.8x | 51.7x | |
$4.2B | 1.2x | 7.1x | |
$4.0B | 2.4x | 13.0x | |
$3.8B | 3.6x | 24.4x | |
$3.8B | 1.8x | 11.5x | |
$3.8B | 5.2x | 24.5x | |
$3.5B | 0.6x | 6.1x | |
$3.3B | 3.1x | 14.0x | |
$3.2B | 1.0x | 6.1x | |
$3.1B | 0.6x | 5.9x | |
$3.1B | 1.4x | 8.4x | |
$2.9B | 6.4x | 23.7x | |
$2.6B | 0.8x | 5.2x | |
$2.6B | 2.2x | -413.9x | |
$2.6B | 1.3x | 10.6x | |
$2.5B | 1.5x | 12.2x | |
$2.5B | 1.1x | 7.4x | |
$2.5B | 1.0x | 4.8x | |
$2.3B | 3.5x | 17.0x | |
$2.3B | 0.8x | 6.7x | |
$2.3B | 1.1x | 8.9x | |
$2.2B | 2.6x | 17.2x | |
$2.1B | 5.3x | 15.0x | |
$2.0B | 3.4x | 19.7x | |
$1.7B | 1.3x | 11.1x | |
$1.6B | 2.6x | 10.9x | |
$1.6B | 0.7x | 7.7x | |
$1.5B | 1.2x | 8.5x | |
$1.4B | 0.8x | 5.4x | |
$1.4B | 4.8x | 10.8x | |
$1.4B | 0.6x | 5.4x | |
$1.2B | 1.7x | 6.7x | |
$1.1B | 7.9x | 27.8x | |
$1.1B | 0.3x | 2.5x | |
$1.1B | 4.2x | 95.3x | |
$1.1B | 1.5x | 10.3x | |
$981M | 2.3x | 9.1x | |
$768M | n/a | n/a | |
$704M | n/a | n/a | |
$665M | 2.1x | -128.7x | |
$648M | 1.4x | 6.8x | |
$618M | 0.5x | 5.7x | |
$615M | 0.8x | 4.5x | |
$591M | 1.5x | 9.8x | |
$580M | 0.8x | 6.0x | |
$496M | 0.3x | n/a | |
$495M | 2.0x | 20.4x | |
$464M | 3.0x | 11.8x | |
$460M | 1.6x | 10.5x | |
$453M | n/a | n/a | |
$434M | 1.1x | 15.8x | |
$415M | n/a | n/a | |
$404M | 1.3x | 24.3x | |
$371M | 1.9x | -25.8x | |
$358M | 1.4x | n/a | |
$346M | n/a | n/a | |
$337M | 0.8x | 10.0x | |
$273M | n/a | n/a | |
$264M | 1.3x | 8.0x | |
$260M | 5.3x | 19.8x | |
$210M | 0.4x | 9.2x | |
$196M | n/a | n/a | |
$191M | 1.0x | 10.5x | |
$167M | n/a | n/a | |
$138M | 2.3x | 7.5x | |
$134M | 0.5x | 6.0x | |
$131M | 2.0x | 9.1x | |
$102M | n/a | n/a | |
$98.8M | 0.4x | 5.2x | |
$59.9M | 1.2x | 9.0x | |
$57.2M | 2.1x | 8.9x | |
$44.6M | n/a | n/a | |
$43.3M | n/a | n/a | |
$33.2M | n/a | n/a | |
$26.4M | n/a | n/a | |
$20.9M | 0.8x | -30.5x | |
$20.9M | 1.6x | n/a | |
$19.4M | n/a | n/a | |
$14.5M | n/a | n/a | |
$12.3M | n/a | n/a | |
$11.7M | n/a | n/a | |
$6.7M | n/a | n/a | |
$1.0M | n/a | n/a | |
$0.8M | n/a | n/a | |
-$2.3M | -0.0x | -0.1x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty